HEATHER PIERSON-RAFFAELE: Open Payments
NPI 1154805026 · SELLERSVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$308 in 15 payments from 8 companies in 2025. Trend: 2023 $339 · 2024 $343 · 2025 $308
Food & beverage: $308
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $96 |
| Novo Nordisk Inc | 2 | $48 |
| GlaxoSmithKline, LLC. | 2 | $45 |
| PFIZER INC. | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 1 | $26 |
| Astellas Pharma US Inc | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| Amgen Inc. | 1 | $17 |
Products named: VRAYLAR, SHINGRIX, BREZTRI, Veozah, Wegovy, XIFAXAN, PREVNAR 20, EVENITY.
Industry payments across PA — which companies pay providers there.
